Catalase inhibition in diabetic rats potentiates DNA damage and apoptotic cell death setting the stage for cardiomyopathy

Journal of Physiology and Biochemistry

Volumn 70, Issue 4, 2014, Pages 947-959

  Ivanović Matić, Svetlana ^a   Bogojević, Desanka ^a   Martinović, Vesna ^a   Petrović, Anja ^a   Jovanović Stojanov, Sofija ^a   Poznanović, Goran ^a   Grigorov, Ilijana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

3 amino 1,2,4 triazole; Apoptotic pathways; Catalase; Diabetic cardiomyopathy; DNA damage; Nrf2 NF B p65 signaling

Indexed keywords

AMITROLE; CATALASE; HYDROGEN PEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAX; PROTEIN BCL 2; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR RELA; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NFE2L2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DNA DAMAGE; ENZYME ACTIVITY; ENZYME INHIBITION; HEART MUSCLE CELL; LIPID PEROXIDATION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; COMPLICATION; DIABETIC CARDIOMYOPATHIES; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; HEART MUSCLE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

RATTUS;

AMITROLE; ANIMALS; APOPTOSIS; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; DNA DAMAGE; ENZYME INHIBITORS; MALE; MYOCARDIUM; NF-E2-RELATED FACTOR 2; NF-KAPPA B; OXIDATIVE STRESS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84911993177     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-014-0363-y     Document Type: Article

References (56)

1. Ahmed D, Kumar V, Verma A, Gupta PS, Kumar H, Dhingra V, Mishra V, Sharma M (2014) Antidiabetic, renal/hepatic/pancreas/cardiac protective and antioxidant potential of methanol/dichloromethane extract of Albizzia Lebbeck Benth. stem bark (ALEx) on streptozotocin induced diabetic rats. BMC Complement Alternat Med 14:243–259
2. Ansley DM, Wang B (2013) Oxidative stress and myocardial injury in the diabetic heart. J Pathol 229:232–241
3. Aronson D (2003) Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 21:3–12
4. Asbun J, Villarreal FJ (2006) The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 47:693–700
5. Asghar O, Al-Sunni A, Khavandi K, Khavandi A, Withers S, Greenstein A, Heagerty AM, Malik RA (2009) Diabetic cardiomyopathy. Clin Sci 116:741–760
6. Bagnyukova TV, Storey KB, Lushchak VI (2005) Adaptive response of antioxidant enzymes to catalase inhibition by aminotriazole in goldfish liver and kidney. Comp Biochem Physiol B 142:335–341
7. Basu A, Haldar S (1998) The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod 4:1099–1109
8. Beutler E (1982) Catalase. In: Beutler E (ed) Red cell metabolism: a manual of biochemical methods. Grune and Stratton, New York, pp 105–106
9. Bukan N, Sancak B, Yavuz O, Koca C, Tutkun F, Ozcelikay AT, Altan N (2003) Lipid peroxidation and scavenging enzyme levels in the liver of streptozotocin-induced diabetic rats. Indian J Biochem Biophys 40:447–450
10. Cai L, Kang YJ (2003) Cell death and diabetic cardiomyopathy. Cardiovasc Toxicol 3:219–228
11. Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, Kang YJ (2006) Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol 48:1688–1697
12. Ceriello A (2003) New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care 26:1589–1596
13. Ceriello A, Morocutti A, Mercuri L, Quagliaro L, Moro M, Damante G, Viberti GC (2000) Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 49:2170–2177
14. D’Amours D, Sallmann FR, Dixit VM, Poirier GG (2001) Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J Cell Sci 114:3771–3778
15. Dreger H, Westphal K, Weller A, Baumann G, Stangl V, Meiners S, Stangl K (2009) Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection. Cardiovasc Res 83:354–361
16. Egorova MV, Afanasèv SA, Popov SV (2005) A simple method for isolation of cardiomyocytes from adult rat heart. Bull Exp Biol Med 140:370–373
17. Fang ZY, Prins JB, Marwick T (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25:543–567
18. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P (2000) Myocardial cell death in human diabetes. Circ Res 87:1123–1132
19. Gechev TS, Hille J (2005) Hydrogen peroxide as a signal controlling plant programmed cell death. J Cell Biol 168:17–20
20. Grimm S, Bauer M, Baeuerle P, Schulze-Osthoff K (1996) Bcl-2 down-regulates the activity of transcription factor NF-kB induced upon apoptosis. J Cell Biol 134:13–23
21. Habig WH, Pabst MJ, Jakoby WB(1974) Gluthathione S-transferases: The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139
22. Hayat SA, Patel B, Khattar RS, Malik RA (2004) Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci 107:539–557
23. He X, Ma Q (2012) Disruption of Nrf2 synergizes with high glucose to cause heightened myocardial oxidative stress and severe cardiomyopathy in diabetic mice. J Diabetes Metab S7:002. doi:10.4172/2155-6156.S7-002
24. Hermes-Lima M (2004) Oxygen in biology and biochemistry: role of free radicals. In: Storey KB (ed) Functional metabolism: regulation and adaptation. Wiley-Liss, Hoboken, pp 319–368
25. Hildeman DA, Mitchell T, Aronow B, Wojciechowski S, Kappler J, Marrack P (2003) Control of Bcl-2 expression by reactive oxygen species. PNAS 100:15035–15040
26. Hou Q, Hsu YT (2005) Bax translocates from cytosol to mitochondria in cardiac cells during apoptosis: development of a GFP-Bax-stable H9c2 cell line for apoptosis analysis. Am J Physiol Heart Circ Physiol 289:H477–H487
27. Huang H, Shan J, Pan XH, Wang HP, Qian LB (2006) Carvedilol protected diabetic rat hearts via reducing oxidative stress. J Zhejiang Univ Sci B 7:725–731
28. Ivanović-Matić S, Mihailović M, Dinić S, Martinović V, Bogojević D, Grigorov I, Poznanovic G (2010) The absence of cardiomyopathy is accompanied by increased activities of CAT, MnSOD and GST in long-term diabetes in rats. J Physiol Sci 60:259–266
29. Izawa S, Inoue Y, Kimura A (1996) Importance of catalase in the adaptive response to hydrogen peroxide: analysis of acatalasaemic Saccharomyces cerevisiae. Biochem J 320:61–67
30. Kumar S, Prasad S, Sitasawad SL (2013) Multiple antioxidants improve cardiac complications and inhibit cardiac cell death in streptozotocin-induced diabetic rats. PLoS ONE 8:e67009. doi:10.1371/journal.pone.0067009
31. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11:376–381
32. Margoliash E, Novogrodsky A, Schejter A (1960) Irreversible reaction of 3-amino-1:2:4-triazole and related inhibitors with the protein of catalase. Biochem J 74:339–348
33. Mariappan N, Elks CM, Sriramula S, Guggilam A, Liu Z, Borkhsenious O, Francis J (2010) NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovasc Res 85:473–483
34. Maritim AC, Sanders RA, Watkins JB (2003) Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17:24–38
35. Matés JM (2000) Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 153:83–104
36. Miao L, St-Clair DK (2009) Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 47:344–356
37. Misra HP, Fridovich I (1972) The role of superoxide anion in the autoxidation of epinephrine and simple assay for superoxide dismutase. J Biol Chem 247:3170–3175
38. Narula J, Kolodgie FD, Virmani R (2000) Apoptosis and cardiomyopathy. Curr Opin Cardiol 15:183–188
39. Ohkawa H, Okishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
40. Pedruzzi LM, Stockler-Pinto MB, Leite M Jr, Mafra D (2012) Nrf2-keap1 system versus NF-kB: the good and the evil in chronic kidney disease? Biochimie 94:2461–2466
41. Pick E, Keisari Y (1980) A simple colorimetric method for the measurment of hydrogen peroxide produced by cells in culture. J Immunol Methods 38:161–170
42. Rizvi F, Shukla S, Kakkar P (2014) Essential role of PH damain and leucine-rich repeat protein phosphatase 2 in Nrf2 suppression via modulation of Akt/GSK3β/Fyn kinase axis during oxidative hepatocellular toxicity. Cell Death Dis 5:e1153. doi:10.1038/cddis.2014.118
43. Ruiz C, Alegría A, Barberá R, Farré R, Lagarda MJ (1999) Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J Clin Lab Invest 59:99–105
44. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, Coskun PE, Ladiges W, Wolf N, Van Remmen H, Wallace DC, Rabinovitch PS (2005) Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 24:1909–1911
45. Shen X, Zheng S, Metreveli NS, Epstein PN (2006) Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes 55:798–805
46. Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantification of low levels of DNA damage in individual cells. Exp Cell Res 175:184–191
47. Szaleczky E, Prechl J, Fehér J, Somogyi A (1999) Alterations in enzymatic antioxidant defence in diabetes mellitus—a rational approach. Postgrad Med J 75:13–17
48. Szymonik-Lesiuk S, Czechowska G, Stryjecka-Zimmer M, Słomka M, Madro A, Celiński K, Wielosz M (2003) Catalase, superoxide dismutase, and glutathione peroxidase activities in various rat tissues after carbon tetrachloride intoxication. J Hepato-Biliary-Pancreat Surg 10:309–315
49. Tamura M, Oschino N, Chance B (1982) Some characteristics of hydrogen and alkylhydroperoxides metabolizing systems in cardiac tissue. J Biochem 92:1019–1031
50. Tan Y, Ichikawa T, Li J, Si Q, Yang H, Chen X, Goldblatt CS, Meyer CJ, Li X, Cai L, Cui T (2011) Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes 60:625–633
51. Villamena AF (2013) Molecular basis of oxidative stress: chemistry, mechanisms, and disease pathogenesis. Wiley, Hoboken
52. Wolff SP, Jiang ZY, Hunt JV (1991) Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 10:339–352
53. Ye G, Metreveli NS, Donthi RV, Xia S, Xu M, Carlson EC, Epstein PN (2004) Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 53:1336–1343
54. Yerra VG, Negi G, Sharma SS, Kumar A (2013) Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-kB in diabetic neuropathy. Redox Biol 1:394–397
55. Young M, McNulty P, Taegtmeyer H (2002) Adaptation and maladaptation of the heart in diabetes: part II: potential mechanisms. Circulation 105:1861–1870
56. Zhang X, Klein AL, Alberle NS, Norby FL, Ren BH, Duan J, Ren J (2003) Cardiac-specific overexpression of catalase rescues ventricular myocytes from ethanol-induced cardiac contractile defect. J Mol Cell Cardiol 35:645–652